Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients

Covert hepatic encephalopathy (CHE) impairs patient quality of life and occurs in approximately 30% of liver cirrhosis (LC) cases. Japanese clinical practice guidelines recommend rifaximin to treat overt HE (OHE). However, the usefulness of rifaximin against CHE is not thoroughly investigated in Jap...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakai, Masato, Suda, Goki, Ogawa, Koji, Yoshida, Sonoe, Hosoda, Shunichi, Kubo, Akinori, Tokuchi, Yoshimasa, Kitagataya, Takashi, Yamada, Ren, Shigesawa, Taku, Ohara, Masatsugu, Sho, Takuya, Morikawa, Kenichi, Sakamoto, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249214/
https://www.ncbi.nlm.nih.gov/pubmed/35776720
http://dx.doi.org/10.1371/journal.pone.0270786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249214/
https://www.ncbi.nlm.nih.gov/pubmed/35776720
http://dx.doi.org/10.1371/journal.pone.0270786

Ejemplares similares